Alpenglow Biosciences, Inc.
Seattle, WA
- UEI
- DVN2AF9A1YV3
- CAGE
- 8BCQ7
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 621511 Medical Laboratories Primary
- SAM.gov registration date
- Physical address
- 2121 N 35th St #100, Seattle, WA 98103, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 3D diagnosis of hirschsprung disease using open-top light-sheet microscopy - abstract hirschsprung disease is a… | National Institute of Diabetes and Digestive and Kidney Diseases | $505,038 | |
| 3D quantification of nash-related liver fibrosis using open-top light-sheet microscopy - abstract non-alcoholic fatty… | National Institute of Diabetes and Digestive and Kidney Diseases | $808,016 | |
| Same-day breast pathology results using open-top light-sheet microscopy for image-guided core needle biopsies - abstract… | National Cancer Institute | $1,593,217 | |
| 3D spatial biology of prostate cancer biopsies for earlier identification of high risk patients - abstract prostate… | National Cancer Institute | $2,045,816 | |
| Open-top light-sheet microscopy for non-destructive 3D pathology of prostate biopsies | National Cancer Institute | $397,742 |
About Alpenglow Biosciences, Inc.
Alpenglow Biosciences, Inc. is a for-profit biotechnology company that provides research and development services focused on advancing diagnostic techniques in disease areas like cancer, diabetes, and digestive and kidney diseases. Through past federal grants, the company has developed platforms to enable rapid imaging and analysis of clinical tissue samples, with a focus on applying open-top light-sheet microscopy and machine learning to improve disease diagnosis.
Specific services provided through federal grants have included: developing multiplex staining protocols and machine learning pipelines for evaluating disease markers in rectal biopsies, liver biopsies, prostate biopsies, and breast cancer biopsies; optimizing open-top light-sheet microscopy imaging and computational pathology techniques to enable same-day breast cancer diagnosis from core needle biopsies; and pioneering the application of 3D microscopy and AI-based tissue analysis to improve disease screening, prognosis, and personalized medicine. Major federal funding has come from the National Institutes of Health's National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, and other agencies under project grants supporting extramural research relevant to agency missions.
Quick answers
What is Alpenglow Biosciences, Inc.'s UEI?
Alpenglow Biosciences, Inc.'s Unique Entity ID (UEI) in SAM.gov is DVN2AF9A1YV3.
What is Alpenglow Biosciences, Inc.'s CAGE code?
Alpenglow Biosciences, Inc.'s CAGE code is 8BCQ7.
What is Alpenglow Biosciences, Inc.'s primary NAICS code?
Alpenglow Biosciences, Inc.'s primary NAICS code is 621511 (Medical Laboratories).
Where is Alpenglow Biosciences, Inc. located?
Alpenglow Biosciences, Inc.'s physical address in SAM.gov is 2121 N 35th St #100, Seattle, WA 98103, USA.
Is Alpenglow Biosciences, Inc. registered in SAM.gov?
Yes. Alpenglow Biosciences, Inc.'s SAM.gov registration is active through March 13, 2027.
What is Alpenglow Biosciences, Inc.'s most recent federal award?
Alpenglow Biosciences, Inc.'s most recent federal grant award is 3D diagnosis of hirschsprung disease using open-top light-sheet microscopy - abstract hirschsprung disease is a… (R43DK133083), from National Institute of Diabetes and Digestive and Kidney Diseases, on April 1, 2022.
On GovTribe
See Alpenglow Biosciences, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors